Frontiers SARS-CoV-2 Spike Protein Expression In Vitro and

4.8 (73) · $ 14.00 · In stock

Severe COVID-19 can be associated with a prothrombotic state, increasing risk of morbidity and mortality. The SARS-CoV-2 spike glycoprotein is purported to d

Frontiers Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model

ACE2: Evidence of role as entry receptor for SARS-CoV-2 and

Frontiers Neuropsychiatric Symptoms of COVID-19 Explained by SARS-CoV-2 Proteins' Mimicry of Human Protein Interactions

SARS‐CoV‐2 spike protein enhances MAP4K3/GLK‐induced ACE2 stability in COVID‐19

Frontiers SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage

Mechanisms of SARS-CoV-2 entry into cells

Aptamer-Mediated Antiviral Approaches for SARS-CoV-2

Frontiers SARS-CoV-2 M Protein Facilitates Malignant

Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities

Microorganisms, Free Full-Text

S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates